Health ❯ Medicine ❯ Pharmaceuticals

Clinical Trials

Phase 3 Studies Alzheimer's Disease Weight Loss Drugs Weight Loss Treatments Efficacy Studies Weight Reduction Obesity Medication Semaglutide Trial Zepbound Clinical Trials Treatment Development Idiopathic Pulmonary Fibrosis Male Birth Control Cannabis Extracts Hereditary Angioedema Experimental Treatments Atopic Dermatitis Donanemab vs Leqembi Obesity Drugs Drug Development Patient Data Analysis Breakthrough Therapy

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Phase 3 trials are set to begin this quarter following 48-week topline data showing large placebo-adjusted weight loss.

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial